Cargando…
Treatment with Tie2-siRNA in combination with carboplatin suppresses the growth of Ishikawa human endometrial carcinoma cell xenografts in vivo
It is well-known that tumor angiogenesis is important in cancer development, and studies on blocking angiogenesis to treat tumors have become one of the most promising and active fields in anticancer research. The present study investigated the effect of siRNA targeting the tyrosine kinase receptor...
Autores principales: | GUO, FEIFEI, XUN, QINGYING, ZHOU, HUAIJUN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3700935/ https://www.ncbi.nlm.nih.gov/pubmed/23833640 http://dx.doi.org/10.3892/ol.2013.1295 |
Ejemplares similares
-
Combined silencing of VEGF-A and angiopoietin-2, a more effective way to inhibit the Ishikawa endometrial cancer cell line
por: Xu, Xiaofeng, et al.
Publicado: (2019) -
The suppression of FOXM1 and its targets in breast cancer xenograft tumors by siRNA
por: Wang, Ming, et al.
Publicado: (2011) -
Combination of imatinib mesylate with lithium chloride and medroxyprogesterone acetate is highly active in Ishikawa endometrial carcinoma in vitro
por: Bilir, Ayhan, et al.
Publicado: (2011) -
Genistein Disrupts Glucocorticoid Receptor Signaling in Human Uterine Endometrial Ishikawa Cells
por: Whirledge, Shannon, et al.
Publicado: (2014) -
Autophagy inhibition augments resveratrol-induced apoptosis in Ishikawa endometrial cancer cells
por: Fukuda, Tomohiko, et al.
Publicado: (2016)